Fengjiao Hu

729 total citations
16 papers, 375 citations indexed

About

Fengjiao Hu is a scholar working on Molecular Biology, Epidemiology and Cancer Research. According to data from OpenAlex, Fengjiao Hu has authored 16 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Epidemiology and 4 papers in Cancer Research. Recurrent topics in Fengjiao Hu's work include Liver Disease Diagnosis and Treatment (5 papers), Signaling Pathways in Disease (4 papers) and Endoplasmic Reticulum Stress and Disease (3 papers). Fengjiao Hu is often cited by papers focused on Liver Disease Diagnosis and Treatment (5 papers), Signaling Pathways in Disease (4 papers) and Endoplasmic Reticulum Stress and Disease (3 papers). Fengjiao Hu collaborates with scholars based in China, Indonesia and South Korea. Fengjiao Hu's co-authors include Song Tian, Hongliang Li, Zhi‐Gang She, Tengfei Ma, Yan‐Xiao Ji, Peng Zhang, Xiao‐Jing Zhang, Yufeng Hu, Han Tian and Xu Cheng and has published in prestigious journals such as Journal of Clinical Oncology, Hepatology and Cell Metabolism.

In The Last Decade

Fengjiao Hu

14 papers receiving 374 citations

Peers

Fengjiao Hu
Brittany Tillman United States
Xianling Dai China
Ahmed Lawan United States
Noriko Shimazu Japan
Julie Pires Da Silva France
Aurore Vluggens United States
Min Tan United States
Alus M. Xiaoli United States
A. Rubenstrunk France
Yong-Jin Kim South Korea
Brittany Tillman United States
Fengjiao Hu
Citations per year, relative to Fengjiao Hu Fengjiao Hu (= 1×) peers Brittany Tillman

Countries citing papers authored by Fengjiao Hu

Since Specialization
Citations

This map shows the geographic impact of Fengjiao Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengjiao Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengjiao Hu more than expected).

Fields of papers citing papers by Fengjiao Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengjiao Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengjiao Hu. The network helps show where Fengjiao Hu may publish in the future.

Co-authorship network of co-authors of Fengjiao Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Fengjiao Hu. A scholar is included among the top collaborators of Fengjiao Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengjiao Hu. Fengjiao Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Li, Jing, Zifeng Yang, Fengjiao Hu, et al.. (2025). Targeted imaging of pulmonary fibrosis by a cyclic peptide LyP-1. Scientific Reports. 15(1). 8098–8098.
3.
Chen, Zhongbao, Fengjiao Hu, Yalong Zhang, et al.. (2023). Ubiquitin-specific protease 29 attenuates hepatic ischemia-reperfusion injury by mediating TGF-β-activated kinase 1 deubiquitination. Frontiers in Immunology. 14. 1167667–1167667. 6 indexed citations
4.
Hu, Sha, Zhen Liu, Fengjiao Hu, et al.. (2023). Tripartite motif 38 alleviates the pathological process of NAFLD–NASH by promoting TAB2 degradation. Journal of Lipid Research. 64(7). 100382–100382. 11 indexed citations
5.
Hu, Fengjiao, et al.. (2023). SWAP70 Overexpression Protects Against Pathological Cardiac Hypertrophy in a TAK1‐Dependent Manner. Journal of the American Heart Association. 12(7). e028628–e028628. 6 indexed citations
6.
Hu, Yufeng, Wenzhi He, Yongping Huang, et al.. (2021). Fatty Acid Synthase–Suppressor Screening Identifies Sorting Nexin 8 as a Therapeutic Target for NAFLD. Hepatology. 74(5). 2508–2525. 70 indexed citations
7.
Zhao, Guang‐Nian, Tian Tian, Han Tian, et al.. (2021). TMBIM1 is an inhibitor of adipogenesis and its depletion promotes adipocyte hyperplasia and improves obesity-related metabolic disease. Cell Metabolism. 33(8). 1640–1654.e8. 43 indexed citations
8.
Lan, Tian, Yufeng Hu, Fengjiao Hu, et al.. (2021). Hepatocyte glutathione S-transferase mu 2 prevents non-alcoholic steatohepatitis by suppressing ASK1 signaling. Journal of Hepatology. 76(2). 407–419. 49 indexed citations
9.
10.
11.
Fu, Jiajun, Fengjiao Hu, Tengfei Ma, et al.. (2021). A conventional immune regulator mitochondrial antiviral signaling protein blocks hepatic steatosis by maintaining mitochondrial homeostasis. Hepatology. 75(2). 403–418. 25 indexed citations
12.
Hu, Fengjiao, Jia Liu, Changhai Li, et al.. (2020). FBXW5 acts as a negative regulator of pathological cardiac hypertrophy by decreasing the TAK1 signaling to pro-hypertrophic members of the MAPK signaling pathway. Journal of Molecular and Cellular Cardiology. 151. 31–43. 11 indexed citations
13.
Zhao, Guojun, Shan Ouyang, Ke‐Qiong Deng, et al.. (2020). Ca 2+ -Dependent NOX5 (NADPH Oxidase 5) Exaggerates Cardiac Hypertrophy Through Reactive Oxygen Species Production. Hypertension. 76(3). 827–838. 47 indexed citations
14.
Zhong, Zhendong, Dandan Yang, Fengjiao Hu, et al.. (2019). Effects of swimming on pain and inflammatory factors in rats with lumbar disc herniation. Experimental and Therapeutic Medicine. 18(4). 2851–2858. 2 indexed citations
15.
Osta, Badi El, et al.. (2016). Immune checkpoint inhibitors (ICI): A meta-analysis of immune-related adverse events (irAE) from cancer clinical trials.. Journal of Clinical Oncology. 34(15_suppl). e14562–e14562. 4 indexed citations
16.
Chang, Lingling, Longhuan Ma, Hua You, et al.. (2014). Acute testicular toxicity induced by melamine alone or a mixture of melamine and cyanuric acid in mice. Reproductive Toxicology. 46. 1–11. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brittany Tillman Breakdown of academic impact, for papers by Xianling Dai Breakdown of academic impact, for papers by Ahmed Lawan Breakdown of academic impact, for papers by Noriko Shimazu Breakdown of academic impact, for papers by Julie Pires Da Silva Breakdown of academic impact, for papers by Aurore Vluggens Breakdown of academic impact, for papers by Min Tan Breakdown of academic impact, for papers by Alus M. Xiaoli Breakdown of academic impact, for papers by A. Rubenstrunk Breakdown of academic impact, for papers by Yong-Jin Kim
Rankless by CCL
2026